大型回顾研究揭示SG和T-DXd序贯治疗的疗效及挑战。转移性乳腺癌（MBC）是一组异质性恶性肿瘤，抗体药物偶联物（ADC）的问世，使得人们开始关注新的分子亚型——HER2低表达乳腺癌。2024年美国临床肿瘤学会（ASCO）大会上，关于ADC治疗HER ...

前言一年一度的肿瘤领域盛会——2024年欧洲肿瘤内科学会亚洲年会（ESMO ...

DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...

Recent advancements in protein engineering, especially antibody-drug conjugates, show promise in lung cancer treatment, with ...

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

Global Cancer Antibody Drug Conjugates Market Will Surpass US$ 50 Billion By 2030 Says Kuick ResearchDelhi, Oct. 23, 2024 ...

浩鼎（4174）执行长王慧君17曰表示，已启动五年新药开发计划，锁定双抗ADC （抗体药物复合体）为竞技国际焦点，并建构平台GlycOBI®，以及特有的EndoSymeOBI®双功能酵素，加入开发双抗ADC的行列，抢攻2029年高达360亿 ...

浩鼎(4174)执行长王慧君指出，将以独家专利ADC技术平台GlycOBI，以及特有的EndoSymeOBI双功能酵素，加入开发双抗ADC的行列。抗体药物复合体(Antibody-Drug Conjugate，ADC)已成当今抗癌新药的主流，光去年销售额即达 ...

The FDA has given clearance to Adcentrx Therapeutics’ IND application for an antibody-drug conjugate (ADC) targeting solid ...

Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024 GlobeNewswire October 23, 2024 SAN FRANCISCO and SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Hummingbird Bioscience, a precision ...

The antibody-drug conjugate market is on an exhilarating growth trajectory, fueled by innovative therapies and precision medicine. With advancements in targeted treatments and a surge in cancer ...